214 related articles for article (PubMed ID: 19958935)
1. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
3. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E
Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
[TBL] [Abstract][Full Text] [Related]
5. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
8. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
9. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
[TBL] [Abstract][Full Text] [Related]
10. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers.
Milas M; Mazzaglia P; Chia SY; Skugor M; Berber E; Reddy S; Gupta M; Siperstein A
Surgery; 2007 Feb; 141(2):137-46; discussion 146. PubMed ID: 17263967
[TBL] [Abstract][Full Text] [Related]
11. [Transcription and promoter hypermethylation of thyroid stimulating hormone receptor gene in human papillary thyroid carcinoma].
Dai YL; Cai DH; Chen H; Zhang Y; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):114-7. PubMed ID: 20117998
[TBL] [Abstract][Full Text] [Related]
12. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697
[TBL] [Abstract][Full Text] [Related]
13. [Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma: clinical analysis of 117 cases].
Shao Y; Cai XJ; Gao L; Li H; Xie L
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):403-5. PubMed ID: 19567120
[TBL] [Abstract][Full Text] [Related]
14. Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.
Besic N; Zgajnar J; Hocevar M; Petric R
Ann Surg Oncol; 2009 Apr; 16(4):920-8. PubMed ID: 19189188
[TBL] [Abstract][Full Text] [Related]
15. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
[TBL] [Abstract][Full Text] [Related]
16. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
[TBL] [Abstract][Full Text] [Related]
17. [Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma].
Yu HZ; Li ZP; Li SG; Wu CM
Ai Zheng; 2005 Jun; 24(6):740-2. PubMed ID: 15946492
[TBL] [Abstract][Full Text] [Related]
18. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
[TBL] [Abstract][Full Text] [Related]
19. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
[TBL] [Abstract][Full Text] [Related]
20. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
